The World Health Organization has listed Covovax, produced by Serum Institute of India under the licence from Novavax, for emergency use. The ninth Covid-19 vaccine approved for emergency use is part of the COVAX facility portfolio and will be boosting efforts in vaccinating people, especially in lower-income countries. Approval after due assessment Covovax was thoroughly … Continue reading India’s COVOVAX gets WHO approval for emergency use